Induction of Regulatory CD4+ Cells and Prolongation of Survival of Fully Allogeneic Murine Cardiac Grafts by Danazol

M Uchiyama, Masateru Uchiyama, X Jin, Xiangyuan Jin, Qi Zhang, Q Zhang, A Amano, Akira Amano, Toshiaki Watanabe, T Watanabe, Masanori Niimi, M Niimi
Transplantation proceedings · 2012 · vol. 44(4) , pp. 1067–1069 · doi:10.1016/j.transproceed.2012.01.103 · PMID:22564626 · W2072662249
article OA: closed CC0 ⤵ 3 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

Danazol treatment induced regulatory CD4+ T cells and extended the survival of fully allogeneic murine cardiac grafts.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

MeSH descriptors

Danazol Graft Rejection Graft Survival Heart Transplantation Immunologic Factors T-Lymphocytes, Regulatory Adoptive Transfer Animals Cell Proliferation Cell Proliferation Cytokines Cytokines Danazol Danazol Flow Cytometry Forkhead Transcription Factors Forkhead Transcription Factors Graft Rejection Graft Rejection Graft Survival

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (11)

Cited by (3)

Source provenance

europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
openalex
last seen: 2026-05-11T06:15:24.675520+00:00
pubmed
last seen: 2026-05-13T22:16:17.081435+00:00
License: CC0 · commercial use OK